EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY 4.0

Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report

Ching-Pei Tsai iD, Kai-Lun Cheng iD, Evelyn Yang, Lung-Yung Huang, Fu-Hui Wang, Man-Jung Hung, Hong-Lin Su iD

PLOS One · 21.05.2025 · 20 (5) · e0324535

DOI: 10.1371/journal.pone.0324535 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift PLOS One, online erschienen am 21.05.2025. Verfasst von Ching-Pei Tsai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Leukocytes, Mononuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital, RONG SING Medical Foundation, Chung Shan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial cystitis (IC) is a complex syndrome characterized by symptoms such as bladder pain, urgency, frequency, and nocturia, without the presence of urinary tract infection or any other identifiable pathology. Traditional treatments, including medication and bladder instillation, are often ineffective in about 30% of patients. Currently, efforts are focused on developing therapies based on the possible pathogenesis of IC. This study is a phase one clinical trial which aimed to investigate the safety and efficacy of autologous peripheral blood mononuclear cell (PBMC) intravesical injections, which have the potential to promote tissue regeneration, as a novel treatment for IC. The study involved isolating PBMCs using the Sepax Cell Separation System and injecting these cells beneath the bladder mucosa layer of patients with IC. Clinical efficacy was evaluated using voiding diaries, questionnaires, and cystoscopic examinations before and 3 months after treatment. Twelve patients with refractory IC participated in this study. Observed side effects, such as pain or urinary tract infection, were mild and transient which demonstrated the safety of this treatment modality. Although the treatment response varied among patients, a third of the patients experienced moderate to significant progress according to the GRA score. Four patients exhibited improvement in bladder glomerulations during postoperative follow-up cystoscopy. In conclusion, the overall safety profile of PBMCs injections appears to be favorable. Further research is needed to optimize treatment protocols and understand the factors influencing individual responses to this therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystitis, InterstitialLeukocytes, MononuclearHumansFemaleMiddle AgedMaleAdministration, IntravesicalAgedAdultTreatment OutcomeCystoscopyUrinary Bladder

Autor:innen und Institutionen

  • Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
  • Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan.
  • Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID-Profile: Ching-Pei Tsai, Kai-Lun Cheng, Hong-Lin Su

Förderung

  • Chung Shan Medical University Hospital
  • RONG SING Medical Foundation
  • Chung Shan Medical University
  • National Chung-Hsing University
  • Industry-Academic cooperation project

Zitieren

APA

Tsai, C. P., Cheng, K. L., Yang, E., Huang, L. Y., Wang, F. H., Hung, M. J., & Su, H. L. (2025). Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report. PLOS One, 20(5), e0324535. https://doi.org/10.1371/journal.pone.0324535

Vancouver

Tsai CP, Cheng KL, Yang E, Huang LY, Wang FH, Hung MJ, et al. Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report. PLOS One. 2025;20(5):e0324535. doi:10.1371/journal.pone.0324535

BibTeX
@article{Tsai2025,
  author = {Tsai, Ching-Pei and Cheng, Kai-Lun and Yang, Evelyn and Huang, Lung-Yung and Wang, Fu-Hui and Hung, Man-Jung and Su, Hong-Lin},
  title = {Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {5},
  pages = {e0324535},
  doi = {10.1371/journal.pone.0324535}
}
Kostenlos starten →